Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 121 |  HQY HealthEquity, Inc | 79.9100 USD | +2.50% | -3.92% | +2.42% | -17.30% | 6.75 B USD | ||
| 122 |  ACLX Arcellx, Inc. Common Stock | 114.8700 USD | +0.03% | +0.10% | +0.41% | +35.03% | 6.72 B USD | ||
| 123 |  PTGX Protagonist Therapeutics, Inc | 97.5700 USD | -1.26% | -5.67% | +4.60% | +29.87% | 6.23 B USD | ||
| 124 |  CNTA Centessa Pharmaceuticals plc American Depositary Shares | 39.5700 USD | +0.23% | -0.43% | +49.38% | +61.38% | 6.12 B USD | ||
| 125 |  TERN Terns Pharmaceuticals, Inc. Common Stock | 52.61 USD | -0.04% | -0.23% | +11.23% | +2207.46% | 6.07 B USD | ||
| 126 |  BRKR Bruker Corporation | 39.05 USD | +3.88% | +6.61% | +14.85% | -1.41% | 5.94 B USD | ||
| 127 |  RYTM Rhythm Pharmaceuticals, Inc. Common Stock | 86.8100 USD | +2.87% | -0.01% | -1.96% | -21.30% | 5.93 B USD | ||
| 128 |  COGT Cogent Biosciences, Inc. Common Stock | 36.5200 USD | +0.41% | +4.37% | -0.73% | +133.06% | 5.93 B USD | ||
| 129 |  KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | 47.3000 USD | +0.47% | -3.96% | +3.39% | +19.31% | 5.88 B USD | ||
| 130 |  BLCO Bausch + Lomb Corporation | 16.5500 USD | +0.42% | +2.03% | +1.10% | +7.33% | 5.86 B USD | ||
| 131 |  PTCT PTC Therapeutics, Inc. | 70.42 USD | +2.52% | +2.19% | +8.71% | +57.36% | 5.83 B USD | ||
| 132 |  MIRM Mirum Pharmaceuticals, Inc. Common Stock | 96.4900 USD | +1.36% | +0.65% | +6.31% | +37.59% | 5.82 B USD | ||
| 133 |  CELC Celcuity Inc. Common Stock | 120.40 USD | +2.78% | +6.14% | +2.80% | +1134.87% | 5.82 B USD | ||
| 134 |  SRRK Scholar Rock Holding Corporation Common Stock | 49.5200 USD | -0.88% | +2.55% | +22.97% | +64.96% | 5.69 B USD | ||
| 135 |  ALKS Alkermes Inc. plc | 33.75 USD | +1.17% | -0.32% | +20.71% | +24.17% | 5.62 B USD | ||
| 136 |  TFX Teleflex Incorporated | 123.22 USD | +3.97% | +7.48% | +13.45% | -5.68% | 5.45 B USD | ||
| 137 |  TGTX TG Therapeutics, Inc. | 33.79 USD | +0.18% | +0.84% | +19.82% | -9.80% | 5.40 B USD | ||
| 138 |  CHE Chemed Corporation | 387.50 USD | +0.49% | +0.96% | -3.73% | -35.72% | 5.33 B USD | ||
| 139 |  LNTH Lantheus Holdings, Inc | 81.6700 USD | +1.34% | +8.35% | +2.09% | +45.68% | 5.28 B USD | ||
| 140 |  CRSP CRISPR Therapeutics AG | 54.83 USD | +7.05% | +11.62% | +10.77% | +37.04% | 5.26 B USD |
Notizie Titoli del Settore Sanitario
Greenwich LifeSciences riporta liquidità di 10,5 milioni di dollari nel Q1
Avanos Medical accetta un’acquisizione da 1,27 miliardi di dollari
Rating outperform confermato per Cellectis su piattaforma allogenica
Harrow: Probably A Short-Term Market Overreaction (NASDAQ:HROW)
US stock futures climb as traders cling to de-escalation hopes, await earnings
Company News for Apr 14, 2026
Novo Nordisk collabora con OpenAI per accelerare la scoperta di farmaci
Gainers Titoli del Settore Sanitario
 QNCX Quince Therapeutics, Inc. Common Stock | 1.41 | +907.14% |
 AKAN Akanda Corp. Common Shares | 3.01 | +377.78% |
 RVMDW Revolution Medicines, Inc. Common Stock | 4.4100 | +123.86% |
 NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0120 | +87.50% |
 VRAX Virax Biolabs Group Limited Ordinary Shares | 0.17 | +70.00% |
 RVMD Revolution Medicines, Inc. Common Stock | 136.3000 | +41.35% |
 GCTK GlucoTrack, Inc. Common Stock | 0.8780 | +32.11% |
 HURA TuHURA Biosciences, Inc. Common Stock | 2.87 | +26.43% |
Losers Titoli del Settore Sanitario
 REPL Replimune Group, Inc. | 1.70 | -64.29% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ONCO Onconetix, Inc. Common Stock | 0.8000 | -26.61% |
 XAIR Beyond Air, Inc. Common Stock | 0.63 | -18.18% |
 QSIAW Quantum-Si Incorporated Class A Common Stock | 0.0900 | -17.20% |
 ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.56 | -15.89% |
 CLGN CollPlant Biotechnologies Ltd Ordinary Shares | 0.32 | -15.79% |
 BFRIW Biofrontera Inc. Common Stock | 0.0400 | -15.61% |